Integrated proteomic, transcriptomic, and epigenomic profiling identifies SRA1 as a novel therapeutic target for postpartum depression
Researchers have identified the SRA1 gene as a potential therapeutic target for postpartum depression using an integrated multi-omics analysis. The study suggests that SRA1 expression and its methylation levels are significantly linked to the risk of developing the condition.
Why it matters
This discovery provides a concrete biological pathway for developing new pharmacological treatments for a common but often undertreated complication of childbirth.
npj Mental Health Research ( 2026 ) Cite this article
We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in